Modifying the dna recombination potential in eukaryotes
CA 2488668 C · Owner: Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food · Inventors: Rozwadowski, Kevin L.; Lydiate, Derek J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides methods of modifying in vivo mutagenesis or homeologous recombination in a eukaryote. The method of modifying in vivo mutagenesis involves transforming a eukaryote with a nucleotide sequence capable of expressing a wild-type prokaryotic MutS MutL, MutH, MutU, NLS-, MutS, NLS-MutL NLS-MutH, NLS-MutU protein, or a combination thereof and , expressing the protein. A method of modifying recombination between homeologous chromosomes in an allopolyploid eukaryotic organism comprising expressing a nucleotide sequence encoding prokaryotic NLS-MutS in combination with one or more than one of NLS-MutL, NLS-MutH NLS-MutU, within a germ cell , of the allopolyploid …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 6, 2003 and granted February 26, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 6, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 6, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.